Pre-Clinical and Clinical Sample Analysis
IMD team has >15 years of experience in development and application of immunoassays for accurate quantification of protein biomarkers and metabolites for both preclinical and clinical samples.
​
The company has established a comprehensive range of automatic and high throughput analytical platforms to address the challenges of the extremely high dynamic range of plasma biomarkers (>12 orders of magnitude from fg/ml to mg/ml), and also developed >100 highly-sensitive and specific immunoassays for protein biomarkers related to major chronic diseases:
![Screenshot 2020-02-04 at 4.32.38 PM.png](https://static.wixstatic.com/media/0fbcf2_be74348d790d4295b898a80d1f72b8f5~mv2.png/v1/fill/w_708,h_425,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Screenshot%202020-02-04%20at%204_32_38%20PM.png)
IMD provides following assay services to academic and clinical researchers, pharmaceutical and biotech industries and medical laboratories for quantitative measurement of single and/or multiple biomarkers in body fluids:
​
-
Selection of most appropriate assay types and methods according to concentration range and sample size;
-
Collection of samples from customers
-
Performing assays with kits developed by IMD or other reliable vendors
-
Analysis and delivery of data to customers
​
​
​
Advantages of IMD assay service
​
Extensive experience in bioassays and biobanks;
​
Advanced analytical platform (single and multiple targets)
​
Capacity to handle thousands of samples within weeks;
​
Strict quality control to minimize batch-to-batch variation;
​
In house assays and high throughput to ensure low cost;
​
Customization of assays according to your requirements
​
Flexible and fast (within 1-2 weeks)
​
​
We develop assays; We know all about them; All you need to do is to send us samples!